Discovery of substituted indole derivatives as allosteric inhibitors ofm6A‐RNAmethyltransferase,METTL3‐14 complex
Authors:
- 18 January 2022
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 83 (3) , 783-799
Abstract
M6A RNA methyltransferase (METTL3-14) catalyzes the methylation of adenosine in mRNA and plays important roles in mRNA functions, and it has been implicated in the progression of multiple cancers, including acute myeloid leukemia (AML). In this study, we describe the discovery of the first allosteric inhibitor of the METTL3-14 complex based on structure–activity relationship (SAR) and optimization studies of the hit compound, 4-[2-[5-chloro-1-(diphenylmethyl)-2-methyl-1H-indol-3-yl]-ethoxy]benzoic acid (CDIBA). Compound 43n was optimized throughout the modifications of 4 different regions of the structure, and it displayed potent enzyme inhibitory activity of the METTL3-14 complex (IC50 = 2.81 μM) and an antiproliferative effect in the AML cell lines by suppressing the m6A level of mRNA. The inhibition mechanism and binding mode of 43n were based on the interaction of the reversible and noncompetitive inhibitory profile at the allosteric site along with selectivity for the METTL3-14 complex relative to each subunit enzyme or truncated complex enzyme.Keywords
Funding Information
- Korea Research Institute of Chemical Technology
This publication has 29 references indexed in Scilit:
- N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cellsNature Cell Biology, 2014
- RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian ClockCell, 2013
- Reversible RNA adenosine methylation in biological regulationTrends in Genetics, 2013
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- Reactions of Functionalized Sulfonamides: Application to Lowering the Lipophilicity of Cytosolic Phospholipase A2α InhibitorsJournal of Medicinal Chemistry, 2009
- Indole Cytosolic Phospholipase A2α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, EfipladibJournal of Medicinal Chemistry, 2008
- Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2αJournal of Medicinal Chemistry, 2007
- Inhibition of Cytosolic Phospholipase A2α: Hit to Lead OptimizationJournal of Medicinal Chemistry, 2005
- Structure-guided Analysis Reveals Nine Sequence Motifs Conserved among DNA Amino-methyl-transferases, and Suggests a Catalytic Mechanism for these EnzymesJournal of Molecular Biology, 1995
- Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivativesJournal of Medicinal Chemistry, 1992